LANOXICAPS SUMMARY
LANOXICAPS®
(digoxin solution in capsules)
mcg (0.1 mg) I.D. Imprint B2C (yellow)
200 mcg (0.2 mg) I.D. Imprint C2C (green)
LANOXIN (digoxin) is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. Digoxin is extracted from the leaves of Digitalis lanata. The term “digitalis” is used to designate the whole group of glycosides. The glycosides are composed of two portions: a sugar and a cardenolide (hence“glycosides”).
Heart Failure
LANOXIN is indicated for the treatment of mild to moderate heart failure. LANOXIN increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, LANOXIN should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these 3 drugs cannot be specified.
Atrial Fibrillation
LANOXIN is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation.
|
